Natixis Purchases New Position in Mettler-Toledo International Inc. (NYSE:MTD)

Natixis acquired a new position in shares of Mettler-Toledo International Inc. (NYSE:MTD) during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 1,817 shares of the medical instruments supplier’s stock, valued at approximately $2,223,000.

A number of other large investors have also modified their holdings of MTD. Barclays PLC raised its stake in shares of Mettler-Toledo International by 8.3% during the third quarter. Barclays PLC now owns 256,602 shares of the medical instruments supplier’s stock valued at $384,822,000 after purchasing an additional 19,609 shares during the period. M&T Bank Corp lifted its holdings in Mettler-Toledo International by 14.3% in the 3rd quarter. M&T Bank Corp now owns 4,926 shares of the medical instruments supplier’s stock worth $7,387,000 after buying an additional 615 shares in the last quarter. Sanctuary Advisors LLC boosted its position in Mettler-Toledo International by 44.4% in the 3rd quarter. Sanctuary Advisors LLC now owns 517 shares of the medical instruments supplier’s stock valued at $775,000 after buying an additional 159 shares during the last quarter. Wilmington Savings Fund Society FSB acquired a new position in shares of Mettler-Toledo International in the third quarter worth about $111,000. Finally, Tidal Investments LLC boosted its holdings in Mettler-Toledo International by 1,073.6% in the third quarter. Tidal Investments LLC now owns 16,407 shares of the medical instruments supplier’s stock valued at $24,606,000 after purchasing an additional 15,009 shares during the last quarter. Institutional investors and hedge funds own 95.07% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of analysts have recently weighed in on MTD shares. Citigroup raised shares of Mettler-Toledo International from a “neutral” rating to a “buy” rating and set a $1,400.00 price target for the company in a research report on Monday, April 7th. Evercore ISI raised their price objective on shares of Mettler-Toledo International from $1,450.00 to $1,475.00 and gave the stock an “outperform” rating in a report on Monday, February 10th. Wells Fargo & Company reduced their price target on shares of Mettler-Toledo International from $1,400.00 to $1,125.00 and set an “equal weight” rating on the stock in a research report on Thursday, April 17th. Finally, Robert W. Baird boosted their price objective on Mettler-Toledo International from $1,362.00 to $1,369.00 and gave the company a “neutral” rating in a report on Monday, February 10th. One research analyst has rated the stock with a sell rating, five have issued a hold rating and four have given a buy rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus target price of $1,346.13.

Insider Buying and Selling

In other Mettler-Toledo International news, insider Christian Magloth sold 790 shares of the firm’s stock in a transaction dated Monday, February 24th. The shares were sold at an average price of $1,313.69, for a total transaction of $1,037,815.10. Following the transaction, the insider now owns 734 shares of the company’s stock, valued at approximately $964,248.46. This trade represents a 51.84 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Gerry Keller sold 600 shares of the company’s stock in a transaction that occurred on Monday, February 10th. The stock was sold at an average price of $1,351.34, for a total transaction of $810,804.00. Following the completion of the sale, the insider now directly owns 6 shares of the company’s stock, valued at approximately $8,108.04. This represents a 99.01 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 1.94% of the company’s stock.

Mettler-Toledo International Trading Down 3.3 %

Shares of NYSE MTD opened at $971.31 on Tuesday. The company has a market cap of $20.24 billion, a price-to-earnings ratio of 23.97, a price-to-earnings-growth ratio of 3.30 and a beta of 1.28. The stock’s 50 day simple moving average is $1,178.59 and its 200 day simple moving average is $1,255.16. Mettler-Toledo International Inc. has a 12-month low of $946.69 and a 12-month high of $1,546.93.

Mettler-Toledo International (NYSE:MTD) last released its quarterly earnings data on Thursday, February 13th. The medical instruments supplier reported $12.41 earnings per share for the quarter, topping analysts’ consensus estimates of $11.76 by $0.65. Mettler-Toledo International had a net margin of 22.29% and a negative return on equity of 591.54%. As a group, equities analysts forecast that Mettler-Toledo International Inc. will post 42.71 earnings per share for the current fiscal year.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.